Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Sevoflurane manufacturers

5 products found

Filters

5 products found

sevoflurane

Inhalation solution 250ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #8191
A pharmaceutical manufacturer based in Europe that has been active in 10+ countries selling its products in Europe, North America, Asia, MENA, and LATAM for 10+ years. The main therapeutic areas include oncology and immunology. The company's production lines are GMP-compliant. The company possesses branches in Europe and MENA.

Additional information about this product will be displayed after sign in.

Create account

Manufacturer usually replies in 9 days

sevoflurane

Inhalation vapour 250 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #22243

Additional information about this product will be displayed after sign in.

Create account

Manufacturer usually replies in 4 days

sevoflurane

Inhalation solution 100 mL, 250 mL.

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #17267
Around 95 years ago the idea of the company was to build a pharmaceutical industry specializing in hospital medicines. The intention was to meet the needs of professionals in those establishments. The company has been producing the most important antibiotics and anesthetics sold to distributors and hospitals across the country.

Additional information about this product will be displayed after sign in.

Create account

Manufacturer usually replies in 2 days

Want to view all 5 products? Create your free account today!

Sevoflurane is a fast-acting inhalable anesthetic agent that is used to induce sleep for patients before surgery. It is marketed as a liquid solution that is turned into vapor and administered to patients orally. Inhalable anesthesia is reportedly associated with lower risks of adverse effects and is more cost-effective than anesthetics that have an intravenous route of administration. And sevoflurane accounts for approximately two-thirds of global inhalable anesthetic drug market share. This is primarily due to its satisfactory effectiveness and lower price. Isoflurane and desflurane – the two primary substitutes in this drug class are typically selected over sevoflurane when there is a need for prolonged maintenance of anesthesia for the patient. Currently, sevoflurane is available in over 120 countries worldwide, with the most popular trade name sevoflurane agent (Ultane) having been used on over 1 billion patients throughout the past 25 years. Its widespread use notwithstanding, most of the global inhalable anesthesia market is split between a limited number of manufacturers and suppliers. The largest suppliers of sevoflurane liquid solutions are AbbVie, Baxter, and Lunan Pharmaceutical. The retail price per 250ml sevoflurane liquid solution is approximately 150-250 EUR.